Angela Raffaella Losito

发表

Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study.

C. Mussini, M. Bassetti, C. Viscoli, 2019, The Journal of infection.

Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units

M. Antonelli, P. Pelosi, M. Mussap, 2017, Critical Care.

Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.

M. Bassetti, C. Viscoli, A. Marchese, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality.

M. Falleni, B. Posteraro, M. Sanguinetti, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Mortality in patients with early- or late-onset candidaemia

F. D. De Rosa, G. di Perri, B. Posteraro, 2012, The Journal of antimicrobial chemotherapy.

Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case–Control Study

M. Bassetti, T. Lupia, F. D. De Rosa, 2020, Open forum infectious diseases.

Risk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital

G. Fadda, B. Posteraro, M. Sanguinetti, 2012, PloS one.

New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review

F. Raffaelli, M. Tumbarello, A. R. Losito, 2022, Antibiotics.

Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes

G. Fadda, T. Spanu, T. D'Inzeo, 2012, Antimicrobial Agents and Chemotherapy.

Identifying Patients Harboring Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System

M. Bassetti, F. D. De Rosa, T. Spanu, 2011, Antimicrobial Agents and Chemotherapy.

Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

M. Bassetti, C. Viscoli, F. D. De Rosa, 2015, The Journal of antimicrobial chemotherapy.

Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.

M. Bassetti, C. Viscoli, R. Cauda, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.

M. Bassetti, C. Viscoli, G. Rossolini, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The role of carbapenem-resistant pathogens in cSSTI and how to manage them

M. Tumbarello, A. R. Losito, Paola Del Giacomo, 2019, Current opinion in infectious diseases.

Identifying Patients Harboring Extended-Spectrum- (cid:1) -Lactamase-Producing Enterobacteriaceae on Hospital Admission: Derivation and Validation of a Scoring System (cid:1)

M. Bassetti, T. Spanu, R. Cauda, 2011 .

Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study

R. de Caterina, W. Ageno, M. Vinceti, 2021, Frontiers in Medicine.

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase–producing K. pneumoniae

S. Antinori, C. Mussini, M. Bassetti, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Use of colistin in adult patients: a cross-sectional study.

M. Bassetti, S. Boni, C. Viscoli, 2020, Journal of global antimicrobial resistance.

Optimizing therapy in CRE infections.

H. Giamarellou, M. Tumbarello, A. R. Losito, 2018, Current opinion in infectious diseases.

Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study.

S. Antinori, M. Meschiari, C. Mussini, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characterisation and risk-factor profiling of P. aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains.

M. Bassetti, T. Spanu, B. Fiori, 2020, International journal of antimicrobial agents.

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)

M. Meschiari, C. Mussini, M. Bassetti, 2020, Open forum infectious diseases.